Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are presently covering the company, Marketbeat.com reports. One research ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Novavax ( (NVAX) ) has issued an announcement. Novavax, Inc. and the UK Health Security Agency have reached a settlement to terminate their ...

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Plus, options traders eye NVAX; CMI surges to fresh peak; and CE looks to extend losing streak.

A new study from the Centers for Disease Control and Prevention (CDC) reveals that fewer than one in six health workers ...

While it is too early to know how this season’s flu will play out, we do know that COVID-19 is still with us.’ ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Åsa ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Agios Pharma (AGIO – Research Report) today. The ...